Congress blocks federal research into transgender youth medical care
S. 5202 — Protecting Our Kids from Harmful Research Act · Filed by Mike Lee (R-UT) · 6 cosponsors · Introduced Jul 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits federal funding for research or publications about gender transition treatments (hormones or surgery) in minors under 18. It defines sex solely by reproductive biology and genetics at birth, and bars funding for studies that would affirm a minor's gender identity if it differs from sex assigned at birth.
Why we flagged it
The bill's operative mechanism is a categorical prohibition on federal research funding for a specific medical topic in a specific population. It does not regulate clinical practice directly, does not criminalize treatment, and does not restrict private funding — it narrows the scope of federally-supported research.
What the text implies
- Blocks not only clinical trials but also observational studies and epidemiological research, which may eliminate data on prevalence, outcomes, and harms/benefits — constraining evidence base for future policy and clinical decisions.
- Defines sex by 'reproductive biology and genetics at birth' — a statutory definition that may have downstream effects on other federal programs, regulations, or legal interpretations if cited as precedent.
- Eliminates federal funding for research but does not restrict private funding, state funding, or international research — may shift research to non-federal sources or other countries, fragmenting evidence base.
- Does not restrict clinical practice itself, only research funding — clinicians may continue prescribing treatments, but the evidence base for those treatments will narrow over time as federally-funded studies cease.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts research funding, which may reduce evidence available to inform medical practice and policy — a potential cost to youth seeking care and clinicians making treatment decisions. However, the bill reflects a legitimate policy disagreement about whether federal funds should support research into pediatric gender transition, a contested medical and ethical question where reasonable people differ on appropriate federal role.
Named in the bill
U.S. Senate, Senate Committee on Health, Education, Labor, and Pensions, National Institutes of Health (implied), Federal research agencies (implied)
Where it stands
6 cosponsors: 6 Republicans.
- Jul 30, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Jul 30, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (841 characters) on Aug 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress blocks federal research into transgender youth medical care” QuorumCivic. https://share.quorumcivic.app/bill/119/s5202 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.